Various studies have depicted osmotin to have exhibited adiponectin mimetic effect toward obesity, diabetes, cardiovascular and neurodegenerative disease [12,13,14,15]. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.